GOODWILL AND OTHER INTANGIBLES (Tables)

12 Months Ended

Dec. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Changes in the Carrying Amount of Goodwill

Changes in the carrying amounts of our goodwill for the years ended December 31, 2023 and December 31, 2022 were as follows (in thousands):

	Branded Pharmaceuticals		Sterile Injectables		Generic Pharmaceuticals		International Pharmaceuticals		Total
Goodwill as of December 31, 2021	$	828,818	$	2,368,193	$	—	$	—	$	3,197,011
Goodwill impairment charges	—		(1,845,000)		—		—		(1,845,000)
Goodwill as of December 31, 2022	$	828,818	$	523,193	$	—	$	—	$	1,352,011
Goodwill as of December 31, 2023	$	828,818	$	523,193	$	—	$	—	$	1,352,011

The carrying amounts of goodwill at December 31, 2023 and December 31, 2022 are net of the following accumulated impairments (in thousands):

	Branded Pharmaceuticals		Sterile Injectables		Generic Pharmaceuticals		International Pharmaceuticals		Total
Accumulated impairment losses as of December 31, 2022	$	855,810	$	2,208,000	$	3,142,657	$	513,211	$	6,719,678
Accumulated impairment losses as of December 31, 2023	$	855,810	$	2,208,000	$	3,142,657	$	525,244	$	6,731,711

Schedule of Other Intangible Assets

Changes in the amounts of other intangible assets for the year ended December 31, 2023 are set forth in the table below (in thousands).

Cost basis:	Balance as of December 31, 2022		Acquisitions		Other (1)		Effect of Currency Translation		Balance as of December 31, 2023
Licenses (weighted average life of 14 years)	$	442,107	$	—	$	(10,000)	$	—	$	432,107
Tradenames	6,409		—		—		—		6,409
Developed technology (weighted average life of 12 years)	5,920,021		—		—		5,641		5,925,662
Total other intangibles (weighted average life of 12 years)	$	6,368,537	$	—	$	(10,000)	$	5,641	$	6,364,178
Accumulated amortization:	Balance as of December 31, 2022		Amortization		Other (1)		Effect of Currency Translation		Balance as of December 31, 2023
Licenses	$	(424,508)	$	(4,576)	$	10,000	$	—	$	(419,084)
Tradenames	(6,409)		—		—		—		(6,409)
Developed technology	(4,204,685)		(251,357)		—		(4,760)		(4,460,802)
Total other intangibles	$	(4,635,602)	$	(255,933)	$	10,000	$	(4,760)	$	(4,886,295)
Net other intangibles	$	1,732,935							$	1,477,883

__________

(1)Other adjustments relate to the removal of certain fully amortized intangible assets.

Schedule of Future Amortization Expense

For intangible assets subject to amortization, estimated amortization expense for the five fiscal years subsequent to December 31, 2023 is as follows (in thousands):

2024	$	246,050
2025	$	232,930
2026	$	209,784
2027	$	134,322
2028	$	112,476